Literature DB >> 16440143

Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.

Tomas Palecek1, Ales Linhart, Jean Claude Lubanda, Sudheera Magage, Debora Karetova, Jan Bultas, Michael Aschermann.   

Abstract

Fabry disease is an X-linked genetic disorder characterized by progressive intracellular accumulation of neutral glycosphingolipids. Cardiac involvement is frequent and left ventricular (LV) diastolic dysfunction is present in most of the affected subjects. Pulsed-wave tissue Doppler echocardiography (PW-TDE) and color M-mode are new Doppler methods for LV diastolic function evaluation. Their role in the assessment of Fabry disease-related cardiomyopathy remains to be established. In this study we aimed to determine the utility of PW-TDE and color M-mode-derived parameters in the assessment of LV diastolic function in patients with Fabry disease. Eighty-one echocardiographic examinations performed in 35 patients affected by Fabry disease were retrospectively analyzed. Early diastolic lateral mitral annular velocity (E(m)) determined by PW-TDE and color M-mode flow propagation velocity (V(p)) were measured and compared to LV filling patterns obtained using standard Doppler indexes. The receiver operating characteristics (ROC) curves method was used to determine the summary measure of relative accuracy for E(m) and V(p). A comparison of ROC curves showed a significant difference for areas under the curve in favor of E(m) (P < 0.001). Pseudonormal filling pattern, higher LV mass index, higher relative wall thickness, larger left atrial diameter, and older age were more frequent (all P < 0.001) in patients with incorrect diagnosis of normal LV diastolic function based on the measurement of V(p). E(m) appears to be superior to V(p) in the assessment of LV diastolic function in patients with Fabry disease. V(p) fails to detect abnormal LV diastolic function in subjects with pronounced concentric LV remodeling and pseudonormal filling pattern.

Entities:  

Mesh:

Year:  2006        PMID: 16440143     DOI: 10.1007/s00380-005-0852-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Characteristics of mitral and tricuspid annular velocities determined by pulsed wave Doppler tissue imaging in healthy subjects.

Authors:  M Alam; J Wardell; E Andersson; B A Samad; R Nordlander
Journal:  J Am Soc Echocardiogr       Date:  1999-08       Impact factor: 5.251

Review 2.  The echo-Doppler evaluation of left ventricular diastolic function. A current perspective.

Authors:  C P Appleton; M S Firstenberg; M J Garcia; J D Thomas
Journal:  Cardiol Clin       Date:  2000-08       Impact factor: 2.213

3.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

4.  Early detection of Fabry cardiomyopathy by tissue Doppler imaging.

Authors:  Maurizio Pieroni; Cristina Chimenti; Roberta Ricci; Patrizio Sale; Matteo Antonio Russo; Andrea Frustaci
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

5.  Echocardiographic determinants of mitral early flow propagation velocity.

Authors:  Paolo Barbier; Antonio Grimaldi; Marina Alimento; Giovanni Berna; Maurizio D Guazzi
Journal:  Am J Cardiol       Date:  2002-09-15       Impact factor: 2.778

6.  Comparison of early diastolic mitral annular velocity and flow propagation velocity in detection of mild to moderate left ventricular diastolic dysfunction.

Authors:  Tomas Palecek; Ales Linhart; Jan Bultas; Michael Aschermann
Journal:  Eur J Echocardiogr       Date:  2004-06

7.  Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging.

Authors:  M J Garcia; L Rodriguez; M Ares; B P Griffin; J D Thomas; A L Klein
Journal:  J Am Coll Cardiol       Date:  1996-01       Impact factor: 24.094

8.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; D D Savage; R J Garrison; K M Anderson; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-04-15       Impact factor: 2.778

9.  Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.

Authors:  A L Klein; L K Hatle; D J Burstow; J B Seward; R A Kyle; K R Bailey; T F Luscher; M A Gertz; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

10.  Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.

Authors:  C P Appleton; L K Hatle; R L Popp
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

View more
  3 in total

1.  Relationship between early diastolic strain rate imaging and left ventricular geometric patterns in hypertensive patients.

Authors:  Hyungseop Kim; Hyun-Ok Cho; Yun-Kyeong Cho; Chang-Wook Nam; Seong-Wook Han; Seung-Ho Hur; Kee-Sik Kim; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

2.  Echocardiographic and electrocardiographic analyses of patients with severe motor and intellectual disabilities.

Authors:  Keiichi Hirono; Tohru Konishi; Hideki Origasa; Fukiko Ichida; Toshio Miyawaki
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

Review 3.  Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future.

Authors:  Roberta Esposito; Ciro Santoro; Giulia Elena Mandoli; Vittoria Cuomo; Regina Sorrentino; Lucia La Mura; Maria Concetta Pastore; Francesco Bandera; Flavio D'Ascenzi; Alessandro Malagoli; Giovanni Benfari; Antonello D'Andrea; Matteo Cameli
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.